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Abstract
It is well recognized that compared with men, women have better ultra-endurance capacity, oxidize more fat during
endurance exercise, and are more resistant to fat oxidation defects i.e. diet-induced insulin resistance. Several groups have
shown that the mRNA and protein transcribed and translated from genes related to transport of fatty acids into the muscle
are greater in women than men; however, the mechanism(s) for the observed sex differences in fat oxidation remains to be
determined. Muscle biopsies from the vastus lateralis were obtained from moderately active men (N= 12) and women
(N= 11) at rest to examine mRNA and protein content of genes involved in lipid oxidation. Our results show that women
have significantly higher protein content for tri-functional protein alpha (TFPa), very long chain acyl-CoA dehydrogenase
(VLCAD), and medium chain acyl-CoA dehydrogenase (MCAD) (P,0.05). There was no significant sex difference in the
expression of short-chain hydroxyacyl-CoA dehydrogenase (SCHAD), or peroxisome proliferator activated receptor alpha
(PPARa), or PPARc, genes potentially involved in the transcriptional regulation of lipid metabolism. In conclusion, women
have more protein content of the major enzymes involved in long and medium chain fatty acid oxidation which could
account for the observed differences in fat oxidation during exercise.
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Introduction
A number of studies have shown that women have a lower
respiratory exchange ratio (RER) compared with men, indicating
higher lipid oxidation and lower carbohydrate (CHO) oxidation
during moderate intensity endurance exercise [1–11]. Further-
more, women have higher whole body lipolysis and greater skeletal
muscle uptake of plasma free fatty acids (FFA) [12], higher
intramyocelluar lipid (IMCL) content [10,13–15] and higher net
IMCL utilization [10,16], as compared to men during endurance
exercise. The potential mechanism(s) of such sex differences have
only recently been evaluated in human based research, but include
sex based differences in gene expression at the RNA and protein
level, sex differences in response to an acute bout of endurance
exercise, and/or hormonal regulation of pathways involved in
metabolism [11,17–20]. Several studies have shown that sex
differences alone are greater predictors of substrate selection than
are age, menstrual cycle phase, 17b-estradiol supplement-
ation, endurance and strength training effects on mRNA content
[20–23].
Skeletal muscle from women shows higher mRNA and protein
content of fatty acid transporter (FAT/CD36) [18], and hormone
sensitive lipase (HSL) [10] than in men. Women also have higher
mRNA expression of lipoprotein lipase (LPL) [18], membrane
fatty acid transport protein 1 (FATm) [17], plasma membrane
fatty acid binding protein (FABPpm) [18], CPT I [24],
trifunctional protein-b (TFPb) [19], peroxisome proliferator
activated receptor-a and d (PPARa, PPARd), cytosolic fatty acid
binding protein (FABPc), sterol regulatory element binding protein
–1c (SREBP-1c), and mitochondrial glycerol phosphate acyltrans-
ferase (mtGPAT) [23] than men. Taken together, these results
suggest that women are transcriptionally programmed for greater
fatty acid transport into the skeletal muscle, b-oxidation, and
IMCL synthesis than men.
Lipid oxidation occurs in the mitochondria through b-
oxidation. Fatty acids (FAs) enter the mitochondria by transporters
CPTI, CPTII and FAT/CD36 [25] or diffusion, depending on
chain length. Women have significantly higher mRNA for CPTI
than men; however, there is no significant sex difference in CPT1
protein or activity [24]. Recent evidence suggests that there are
FAT/CD36 transporters on the mitochondrial membrane [25–26]
and although sex differences in the mitochondria specific
population have not been examined, women have significantly
greater FAT/CD36 protein in whole muscle homogenate
compared with men [18], which may allow for greater
mitochondrial uptake of long chain fatty acids (LCFAs) in women.
There are four major enzyme activities in the b-oxidation
pathway; acyl-CoA dehydrogenases, enoyl-CoA hydrateses, 3-
hydroxyacyl-CoA dehydrogenases, and 3-ketoacyl-CoA thiolases
[27]. At least three enzymes with activities toward different
substrates perform the first reaction, very long-, medium-, and
short chain acyl-CoA dehydrogenases (VLCAD, MCAD, and
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SCAD, respectively). The second through fourth reactions for long
chain substrates are found on the mitochondrial trifunctional
protein (TFP), a heteroctamer made of each of a and b subunits.
Sex based differences of b-oxidation enzymes have only recently
been studied. The mRNA content of b-hydroxyacyl-CoA
dehydrogenase [b-HAD, also known as short-chain b-OH acyl-
CoA dehydrogenase (SCHAD)] is greater in women compared
with men; however, there is no sex difference in b-HAD activity
[11]. Similarly, women have higher levels of acyl-CoA acyltrans-
ferase 2 (ACAA2) mRNA with no sex specific difference in protein
content [19]. Both b-HAD (SCHAD) and ACAA2 are responsible
for short chain FA oxidation, but long chain- and medium chain-
acyl-CoA oxidation has not been compared between the sexes.
Due to the convincing evidence that women have greater whole
body FA oxidation and uptake of FAs during exercise than men,
we hypothesized that there would be sex differences in the protein
capacity for LCFA oxidation in human skeletal muscle.
The purpose of this study was to evaluate the effect of sex on the
mRNA expression and protein content of genes involved in b-
oxidation (VLCAD, MCAD, TFP-a, SCHAD) and potential
regulators of these proteins (PPARa, and PPARc) in human skeletal
muscle. We specifically hypothesized that the mRNA and protein
content for the genes involved in lipid metabolism would be higher
in women than men.
Materials and Methods
The study was approved by the McMaster University Hamilton
Health Sciences Human Research Ethics Board and conformed to
the Declaration of Helsinki guidelines.
Subjects
Twenty-three, young (2262 y) healthy, non-smoking, non-
obese, recreationally active men (n= 12) and women (n= 11)
participated in the current study. The subject characteristics are
described in Table 1. Men and women were matched based on
peak O2 consumption (VO2peak) expressed as milliliters per
kilogram fat-free mass per minute. Women were in the follicular
phase of their menstrual cycle (day 3–13). All subjects gave
informed written consent prior to participation.
Study design
At least one week prior to testing, subjects completed a whole
body DEXA scan and progressive VO2peak test on a stationary
electronically braked cycle ergometer and a computerized open-
circuit gas collection system (Moxus Modulator VO2 system with
O2 analyzer S-3A/I and CO2 analyzer CD-3A, AEI Technologies
Inc., Pittsburgh, PA) as previously described [1,5,7–8]. Subjects
completed diet records for three days leading up to testing (no
significant difference in percent fat, carbohydrate or protein intake
between men and women, data not shown), and did not exercise
48 h before testing. Subjects were asked to refrain from eating
after 2100 h the day before testing and were given a defined
formula drink (Ensure PlusH, Abbott Laboratory Inc., Saint-
Laurent, Quebec, Canada) 2 h before baseline blood and muscle
biopsies were acquired. All samples were taken in the morning.
Blood was collected and resting glucose and lactate levels were
determined using a blood-gas analyzer (Radiometer ABL800
FLEX, Copenhagen, Denmark) (no significant difference between
men and women, data not shown). Serum estradiol levels were
evaluated using a human estradiol ELISA kit; Fertigenix-E2-
EASIA (Biosource Europe S.A, Nivelles, Belgium) (no significant
difference between men and women, data not shown). Muscle
biopsies (,150 mg) were taken from the vastus lateralis muscle
before 90 min of stationary cycling at 65% of their VO2peak. The
muscle was rapidly placed in an RNase-free polyethylene tube,
flash-frozen in liquid nitrogen, and stored at 280uC until being
processed for analysis. Respiratory measures (oxygen uptake,
expired CO2, and RER) were taken using the computerized open-
circuit gas collection system, and fat and glucose oxidation rates
were determined using the non-protein respiratory quotient [28],
and percentage fat and glucose utilized was determined as
previously described [2]. Respiratory measures were taken from
10–15 min, 30–40 min and 60–70 min during the ride. The
subjects maintained the same pedaling cadence (rpm) throughout
the ride. At each time point the wattage was adjusted (if needed) so
that the subjects maintained 65% of their V02peak. Data used to
express the respiratory measures (oxygen uptake, expired CO2,
and RER) were taken from the 30 and 60 min time points and
averaged together to represent RER over 30 min in the middle of
the exercise bout. These data points ensure the subjects were at a
steady state.
Preparation of RNA
Fifty milligrams of human muscle was used to isolate total RNA
using mirVanaTM RNA isolation kit (Ambion Inc., Austin, TX
#AM1561). In brief, muscle tissue was homogenized in lysis/
binding buffer in a glass homogenizer. The RNA was extracted
organically using acid-phenol:chloroform and ethanol precipita-
tion. Final isolation was done using provided filter cartridges. RNA
was eluted in nuclease-free water and quantity and quality of RNA
was assessed using a NanoDrop Spectrophotometer (Thermo
Scientific, Wilmington, DE). Measurements were done in
duplicate and had an average coefficient of variation (CV) of
,10%. The average purity (OD260/OD280) of the samples was
.1.8.
TaqManH real-time RT-PCR
First-strand cDNA synthesis from 100 ng of total RNA was
performed with random primers using a High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems Inc., Foster City,
CA Cat#4368814) according to manufacturer’s directions. Gene
expression was quantified using 7300 Real-time PCR System
(Applied Biosystems Inc., Foster City, CA) and SYBRH Green
chemistry (PerfeCTa SYBRH Green Supermix, ROX, Quanta
BioSciences, Gaithersburg, MD) as previously described [29].
Specific primers to each target mRNA (Table 2) were designed
based on the cDNA sequence in GenBank with MIT primer 3
designer software. Thermal dynamics was optimized through
calculating delta G with Analyzer of Oligo. Primer specificity was
Table 1. Subject characteristics.
Men (n=12) Women (n=11)
Age (yr) 2161 2061
Weight (kg) 8365 6661 a
Height (cm) 18163 16761 a
Body Fat (%) 1762 3261 b
Fat Mass(kg) 1462 2066 b
Fat Free Mass (kg) 6663 4261 a
VO2peak (ml*kg body wt-1*min-1) 4462 3962 a
VO2peak(ml*kg FFM-1*min-1) 5662 6063
Data are means 6SE. a; significantly lower in women P#0.05, b; significantly
higher in women P#0.05.
doi:10.1371/journal.pone.0012025.t001
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checked using Blast and RT-PCR dissociation curves. All samples
were run in duplicate on a 96-well plate. Each target gene was run
in parallel with human b2- microglobulin (b2-M) as an internal
standard with RNA- and RT-negative controls.
Immunoblotting analysis
Thirty mg of tissue were used for protein content analysis.
Muscle tissue was homogenized in a phosphate lysis buffer; 50mM
K2HPO4, 1mM EDTA, pH7.4, 0.1mM DDT, PhosSTOP (Roach
Diagnostics, Mannheim, Germany), Protease inhibitor cocktail
tablets (Roach). Protein concentrations were calculated by
Bradford assay (Bio-Rad Laboratories, Hercules, CA) and equal
amounts of protein were boiled in Laemmli buffer, resolved by
SDS-PAGE, transferred to nitrocellulose paper or PVDF and
immunoblotted with desired antibodies. Primary antibodies;
VLCAD and MCAD (Dr. J. Vockley), HADHA (TFP-a) (Protein
Tech Group, Chicago, IL), SCHAD (Abcam, Cambridge, MA),
PPARa (Santa Cruz Biotechnology, Santa Cruz, CA), PPARc
(Cell Signaling Technology, Danvers, MA), actin (Abcam) and
citrate synthase (CS) (Dr. B. Robinson, Sick Kids Hospital,
Toronto). There were no sex differences in protein content of
citrate synthase (mitochondrial content) or actin (total myofibrillar
and cytosolic protein loading). Actin and ponceau were used as
loading controls. Secondary antibodies conjugated to horseradish
peroxidase (Amersham Bioscience, UK) and specific antibody
binding was detected using the chemiluminescence detection
reagent ECL Plus (Amersham BioScience, UK). Scanned films
were analyzed using ImageJ 1.40 software (Wayne Rasband
National Institute of Health, USA).
Statistical Analysis
Statistical analyses of mRNA expression of the genes were
performed by subtracting the linear CT (22CT) of the house
keeping gene (b2-M) from the linear CT of gene of question [30].
Statistical analysis of gender differences in mRNA and protein
content (6SE) were calculated using a Student’s t-test. Correlation
analysis (Pearson’s) was used to determine the relationship
between RER and protein content in all subjects. Statistical
significance was set at a#0.05.
Results
Subject Characteristics
Women had significantly lower body weight, height, fat free
mass (FFM), and VO2peak per kilogram body weight (P#0.05)
compared with men (Table 1). When VO2peak was expressed
relative to FFM there was no significant difference between
men and women. During exercise women had a significantly
lower RER (0.8760.02) than men (0.9160.01) (P#0.05)
(Table 3).
Sex differences in key enzymes of the b-oxidation
pathway
VLCAD. There was no sex difference in the mRNA
abundance of VLCAD (Figure 1 A). Women had a 2.560.4 fold
(P= 0.001) higher protein content of VLCAD compared with
men (Figure 1B, C). VLCAD protein content had a significant
correlation with RER (r2 = 0.35, P = 0.001).
MCAD. There was no sex difference in the mRNA
abundance of MCAD (Figure 2 A). Women had a 2.660.6 fold
(P= 0.007) higher protein content of MCAD than men (Figure 2
B, C). MCAD protein content had a significant correlation with
RER (r2 = 0.21, P = 0.01).
Table 2. Real-time PCR primer sequences.
Gene Accession Forward primer (59-39) Reverse primer (59-39)
VLCAD BC012912 gtggccgctttctgtctaac ccttcgttcgaaacctagtc
MCAD AF251043 tgccagagaggaaatcatcc tctcggacccttgaaccaaa
TFPa BC009235 gagttgacccgaagaagctg aaccacacctacatcgcttt
SCHAD BC000306 cgttgtccacagcacagact gacctgttcaaacgacgact
b2M NM_004048 ggctatccagcgtactccaa gatgaaacccagacacatagca
doi:10.1371/journal.pone.0012025.t002
Table 3. Substrate oxidation in men and women cycling at
65% VO2peak.
Men Women
RER 0.9160.01 0.8760.02 *
Fat oxidation (g/min) 0.3660.06 0.3860.05
Glucose oxidation (g/min) 2.3660.14 1.3160.12 *
Fat oxidation (%) 29.663.5 45.064.9 *
Glucose oxidation (%) 70.463.5 55.064.9 *
Data are means 6SE, RER; respiratory exchange ratio, *P#0.05.
doi:10.1371/journal.pone.0012025.t003
Figure 1. VLCAD protein content is higher in women than men.
Differences in VLCAD mRNA content between men and women shown
by Real time RT-PCR, adjusted to b2-M mRNA (A). Protein content of
VLCAD in skeletal muscle of men and women, adjusted to CS (B,C).
Representative western blot (B) Lanes 1–4 are men, lanes 5–8 women.
N = 12 men and 11 women. *P#0.05.
doi:10.1371/journal.pone.0012025.g001
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TFP- a. Women had a significantly lower abundance
(21.460.1 fold p= 0.004) of TFP-a mRNA compared with men
(Figure 3A). Women had a 1.560.1 fold (P,0.001) higher protein
content of TFP-a than men (Figure 3B, C). TFP-a protein content
had a significant correlation with RER (r2 = 0.23, P = 0.02).
SCHAD. There was no sex difference in the mRNA abundance
or protein content of SCHAD (Figure 4). There was no correlation
between SCHAD protein content and RER (r2=0.0004, P=0.46)
Regulation of lipid metabolism
There was no sex difference in the protein content of PPARa
and PPARc (Figure 5); two transcription factors involved in the
regulation of mitochondrial FA oxidation proteins. There was no
correlation between either PPARa or PPARc protein content and
RER (r2 = 0.06, P= 0.17; r2 = 0.004, P= 0.4)
Discussion
This study shows that women have a higher protein content of
VLCAD, MCAD and TFPa than men, suggesting that women
have a higher capacity for b-oxidation of LCFAs. Previous
research has shown that there is a sex difference in FATm mRNA
[17], FABPpm protein and mRNA, FAT/CD36 protein and
mLPL [18] these results indicate that as compared with men,
women have a higher capacity for fatty acid transport. Taken
together, these results suggest women have a higher capacity than
men for LCFA utilization; including skeletal muscle up-take and
b-oxidation within mitochondria at rest and during exercise.
These results are in agreement with our hypothesis and directly
support previous observations that women oxidize more fat than
men during endurance exercise [1–9,31–33].
We conducted a comparative analysis by matching men and
women based on their aerobic capacity expressed per unit fat-free
mass (VO2peak?kg FFM
21?min21). We [1,6–8,33–37] and others
[2–3,38] consistently match men and women using VO2peak per kg
FFM per min because endurance training is known to alter
substrate utilization, increasing reliance on lipid sources and
reducing the reliance on carbohydrates [5,39–40]. Furthermore,
we controlled for mitochondrial content by comparing CS protein
content and observed no sex difference in total amount. Our data,
taken together with previous findings that matched men and
women have similar mitochondrial volume densities [34] and
similar enzyme activities of CPT1 [24], 3-b-hydroxyacyl CoA
dehydrogenase, citrate synthase, succinate-cytochrome c oxidore-
ductase, and cytochrome c oxidase [34], we believe our paired
subjects to be well matched.
Women, having a higher abundance of VLCAD and MCAD
than men, also showed a higher potential for utilization of straight-
chain FAs. VLCAD and MCAD are two of the nine identified
acyl-CoA dehydrogenases, and have broad chain-length enzyme
activity raging from 4–16 carbon FA (MCAD) and 12–24 carbon
(VLCAD) [41]. Trifunctional protein is a heterooctamer com-
posed of 4a- and 4b-subunits. The alpha subunit, from the
HADHA gene [42], has enzyme activity to hydrolyze long-chain
enoyl-CoA and oxidize long-chain 3-hydroxyacyl-CoAs of 10
Figure 2. MCAD protein content is higher in women than men.
Differences in MCAD mRNA content between men and women shown
by Real time RT-PCR, adjusted to b2-M mRNA (A). Protein content of
MCAD in skeletal muscle of men and women, adjusted to CS (B,C).
Representative western blot (B) Lanes 1–4 are men, lanes 5–8 women.
N = 12 men and 11 women. *P#0.05.
doi:10.1371/journal.pone.0012025.g002
Figure 3. TFPa protein content is higher in women than men.
Differences in TFPamRNA content between men and women shown by
Real time RT-PCR, adjusted to b2-M mRNA (A). Protein content of TFPa
in skeletal muscle of men and women, adjusted to CS (B,C).
Representative western blot (B) Lanes 1–5 are men, lanes 6–10 are
women. N= 12 men and 11 women. *P#0.05.
doi:10.1371/journal.pone.0012025.g003
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carbon chain-length and greater [43]. During exercise, FAs
contribute anywhere from 30–70% of substrate utilized (depend-
ing on exercise intensity) [44], of which ,90% are LCFAs [45].
The percentages of the predominant LCFA relative to the total
plasma FFA are ,43% oleate, ,30% palmitate and ,14%
stearate [46]. This ratio is consistent at rest and does not change
significantly during exercise [46] despite the large change in flux.
However, LCFA kinetics in skeletal muscle do not reflect plasma
concentrations, with women showing an increase in IMCL
utilization during exercise compared with men [16]. Given the
higher IMCL content, the close proximity of IMCL’s to
mitochondria [15] and the significantly greater protein abundance
of VLCAD, MCAD and TFPa in women compared to men may
help to explain the mechanism behind the observed sex difference
in lipid oxidation during endurance exercise.
In order to elucidate the potential transcriptional mechanism
regulating the increase protein content of VLCAD, MCAD and
TFPa we looked at protein content of PPARa and PPARc. Our
data show no significant difference in the total amount of these
transcription factors in whole muscle homogenate. Recent work
from our lab showed that there is a greater constitutive expression
of two of the genes encoding key modulators of fat oxidation
(PPARa and PPARd) in women compared with men [19]. PPARa
is a transcriptional activator of MCAD, CPTI, CPTII, FABP and
FATP [47–48], whereas PPARd transcriptionally activates FABPc,
FAT/CD36, LPL, CPTI, and genes involved in b-oxidation [49–
51]. Less is known about the role of PPARc in skeletal muscle.
PPARc has 2 splice varents; PPARc1 and PPARc2, and it is
PPARc1 that is expressed in skeletal muscle and has greater
expression in oxidative fibers [52]. The most convincing evidence
for PPARc1’s role in metabolism is that genetic skeletal muscle
PPARc1 knockout mice are less responsive to thiazolidinedione (a
PPARc inhibitor) treatment compared with wild-type controls,
and were more susceptible to insulin resistance [53]. Furthermore,
genetic activation of PPARc1 in mouse skeletal muscle protected
against high-fat diet-induced insulin resistance, reduced myocyte
lipid content and improved muscle oxidative fibers, either directly
or indirectly (through the release of adiponectin), increasing genes
involved in lipid oxidation and mitochondria function [54–56].
Here we show that there is no significant difference in PPARa or
PPARc protein content between men and women. The lack of
difference in protein content of PPARa despite differences in
mRNA is consistent with similar findings with PPARd [19].
Although changes in total protein content are not different
between men and women, transcription factors rely on nuclear
abundance and translocation into the nucleus to elicit changes in
RNA expression. Future studies should include sex differences in
nuclear abundance of these transcription factors. Also, we cannot
negate that recent studies in skeletal muscle biology have also
found discrepancies in the correlation between mRNA and protein
content of a number of genes related to fatty acid oxidation
[10,18,57]. Part of the discrepancy between mRNA abundance,
protein content, and enzyme assays may be that multiple small
changes in interacting and synergistic pathways/factors combine
to influence flux through metabolic pathways at the protein level,
and that each change is below the detectable threshold for
Figure 4. SCHAD protein content is equal in women and men.
SCHAD mRNA content between men and women shown by Real time
RT-PCR, adjusted to b2-M mRNA (A). Protein content of SCHAD in
skeletal muscle of men and women, adjusted to CS (B,C). Representative
western blot (B) Lanes 1–4 are men, lanes 5–8 women. N= 12 men and
11 women.
doi:10.1371/journal.pone.0012025.g004
Figure 5. No sex differences in PPARa or PPARc protein
content. Protein content of PPARa (A) and PPARc (B) in skeletal
muscle of men and women, adjusted to actin. Representative western
blots; lanes 1–4 are men, lanes 5–8 women. N= 12 men and 11 women.
doi:10.1371/journal.pone.0012025.g005
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statistical significance. It could also be the technical sensitivity of
RT-PCR compared with the higher variance in Western blots and
activity assay techniques. Regardless, in order to fully understand
cellular differences between men and women it is important to
understand pre-translational (mRNA abundance), translational
(protein) and post-translational (phosphorylation, degradation)
levels of control.
One of the possible contributing factors for the observed sex
difference could be estrogen effects. Research using rodents
[58–60] and humans [35–36,61–62] has suggested that estrogen
may play a role in regulating substrate utilization. The admi-
nistration of 17b-estradiol to amenorrheic women [62] and to men
[35–36,61] lowers the respiratory exchange ratio during exercise
[35–36,61–62], reduces whole body carbohydrate and leucine
oxidation. It also increases lipid oxidation in men [36], increases
plasma FFA concentration [62] and reduces glucose rate of
appearance [35,61–62], rate of disappearance and metabolic
clearance rate [35,61]. In favor of a direct role for estrogen in sex
differences in substrate utilization, database searches reveal that
MCAD, SCHAD, PPARa, PPARd, and PPARc have up-stream
estrogen response elements (ERE) [63] suggesting these genes may
be regulated by estrogen.
In conclusion, our results show that women have higher
VLCAD, MCAD, and TFPa protein than age and fitness matched
men. Our findings offer an explanation for the observed sex
differences in lipid oxidation. Taken together with the evidence
that women have greater FA transport capabilities in skeletal
muscle, we can conclude that women are more efficient at using
lipid as a substrate during endurance exercise than men.
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